A Phase III Study of Siltumaximab (CNTO 328) Anti Interleukin 6 Monoclonal Antibody in Metastatic Renal Cell Cancer.2010

February 21, 2017 | Author: Fina Herlinda Nur | Category: N/A


Description

Download A Phase III Study of Siltumaximab (CNTO 328) Anti Interleukin 6 Monoclonal Antibody in Metastatic Renal Cell Cancer.2010

Comments

SUPPORT DOCURI